Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defibrotide in COVID-19 Pneumonia
NCT04335201Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- May 2020
- Primary completion
- Apr 2021
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of defibrotide in COVID-19 pneumonia, sponsored by IRCCS Ospedale San Raffaele. Started May 2020; status: completed.
02
Drugs
defibrotide
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04335201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04335201.